about
Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesHistopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation.Recent advances in animal models of systemic sclerosis.Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease.Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series.Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis.Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.Recent advances in the treatment of skin involvement in systemic sclerosis.IL-17 and related cytokines involved in systemic sclerosis: Perspectives.A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis.Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.Angiotensin II Type 1 receptor (AGTR1) gene polymorphisms are associated with vascular manifestations in patients with systemic sclerosis (SSc).The Convergence of Vasculopathy and Vasculitis: Computer Mapping Analysis of 2 Renal Biopsies in a Patient with both Systemic Sclerosis and ANCA-Related Vasculitis.The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis.Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and ChallengesVascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
P2860
Q36371453-C78E5FF0-D895-410E-BBBA-0D07D0C002C0Q37381549-42F122CA-3095-453E-9852-A2B9B23863D2Q37582535-9134743F-A396-45F1-A76E-A7458C4FD027Q38701983-21F636A9-34C7-4EDB-884B-44581CE7D6DCQ39476929-8AFEA599-9BB7-4197-9189-C07DF7E7AE06Q39997850-38BAEB8E-3117-47C2-843B-48C91D640B1CQ40316188-119C4350-0351-4A6D-A7C0-A4C67009B2ABQ40321155-0613B5B0-12F8-493E-808D-BDD4A3801064Q40371203-E16F8AF3-8A89-4884-B840-4E9F34C5ED18Q40393079-3F5A3AB0-1E09-4C64-94D7-274846606BABQ40400741-3363610D-4C68-43E9-BBC4-882DD2AF5563Q41169103-D8CC6DF7-35D1-48CA-B48D-95222400BB05Q41980258-1E891680-BC27-472D-977C-B2AD3C558523Q42379517-B68450C7-A6F5-48BA-9E38-159059DE2722Q47111024-9DCE9DFB-CA44-4E99-A924-F8FC3997CF45Q47774368-C5988E6F-1D55-49FB-968C-CCCA25803101Q48177844-C73CBF0F-3C2B-4D8A-85E3-154F35F67FCCQ48245847-0FAFE29A-CB1B-432E-956B-E4EA0FB5FEABQ49906728-4AEFCCB4-D759-47D7-B12C-07F68E94AB2CQ49989946-8D9923A8-ABE5-455D-B03C-A686AB23F980Q51476905-F5B5BE7E-B137-4440-A83C-BA17A61BF84CQ52564506-89D09F79-BE1B-4A8F-891B-9E8C57A9EBB8Q55402074-BA8A7CEA-6F5F-4114-8B5F-E2CC3BFA88F3Q56977476-9B799AE5-9EAB-42AA-8DB5-E0B1239B53BAQ57110619-B8CDBE04-856A-466C-A478-AD464981BB0AQ58758876-C90BEAA6-1699-42C4-955D-D28E570163F8Q58797878-AD81CFE7-C113-4E7C-8AB1-A979F9A5D0C5
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Vasculopathy in scleroderma.
@en
type
label
Vasculopathy in scleroderma.
@en
prefLabel
Vasculopathy in scleroderma.
@en
P2860
P1476
Vasculopathy in scleroderma.
@en
P2093
Shinichi Sato
Yoshihide Asano
P2860
P2888
P304
P356
10.1007/S00281-015-0505-5
P577
2015-07-08T00:00:00Z
P6179
1022353333